Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | USP2 | O75604 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1232002 | 0.92 | MEN1 (0.52) | MEN1KMT2ATSHRUSP2ALDH1A1 | |
| SCHEMBL3181704 | 0.92 | MEN1 (0.52) | MEN1KMT2ATSHRUSP2ALDH1A1 | |
| SCHEMBL18548563 | 0.92 | MEN1 (0.52) | MEN1KMT2ATSHRUSP2ALDH1A1 | |
| SCHEMBL267534 | 0.92 | MEN1 (0.52) | MEN1KMT2ATSHRUSP2ALDH1A1 | |
| SCHEMBL3185849 | 0.92 | MEN1 (0.52) | MEN1KMT2ATSHRUSP2ALDH1A1 | |
| SCHEMBL996469 | 0.92 | MEN1 (0.52) | MEN1KMT2ATSHRUSP2ALDH1A1 | |
| SCHEMBL661021 | 0.89 | USP2 (0.52) | TSHRUSP2ALDH1A1KDM4ELMNA | |
| SCHEMBL660625 | 0.89 | USP2 (0.52) | TSHRUSP2ALDH1A1KDM4ELMNA | |
| SCHEMBL101673 | 0.89 | USP2 (0.52) | TSHRUSP2ALDH1A1KDM4ELMNA | |
| SCHEMBL6555279 | 0.89 | USP2 (0.52) | TSHRUSP2ALDH1A1KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1430082-A4 | METHODS OF SYNTHESIZING INSULIN POLYPEPTIDE-OLIGOMER CONJUGATES, AND PROINSULIN POLYPEPTIDE-OLIGOMER CONJUGATES AND METHODS OF SYNTHESIZING SAME | NOBEX CORP (US) | 2004-11-24 | — | — | EP | disclosed |
| EP-1430082-A2 | METHODS OF SYNTHESIZING INSULIN POLYPEPTIDE-OLIGOMER CONJUGATES, AND PROINSULIN POLYPEPTIDE-OLIGOMER CONJUGATES AND METHODS OF SYNTHESIZING SAME | Nobex Corporation (US) | 2004-06-23 | — | — | EP | disclosed |
| WO-2003022210-A2 | PHARMACEUTICAL COMPOSITIONS OF DRUG-OLIGOMER CONJUGATES AND METHODS OF TREATING DISEASES THEREWITH | NOBEX CORPORATION (US) | 2003-03-20 | — | — | WO | disclosed |
| WO-2003022208-A2 | PHARMACEUTICAL COMPOSITIONS OF INSULIN DRUG-OLIGOMER CONJUGATES AND METHODS OF TREATING DISEASES THEREWITH | NOBEX CORPORATION (US) | 2003-03-20 | — | — | WO | disclosed |
| WO-2003022996-A2 | METHODS OF SYNTHESIZING INSULIN POLYPEPTIDE-OLIGOMER CONJUGATES, AND PROINSULIN POLYPEPTIDE-OLIGOMER CONJUGATES AND METHODS OF SYNTHESIZING SAME | NOBEX CORPORATION (US) | 2003-03-20 | — | — | WO | disclosed |